Drug intelligence / Profile preview

2-(3'-methoxyphenyl) benzimidazole-4-carboxamide

Development stage
Unknown
Modality
Small Molecules
01

Overview

2-(3'-Methoxyphenyl) benzimidazole-4-carboxamide is a synthetic small molecule belonging to the phenylbenzimidazoles class. It is primarily recognized as an experimental compound with no current clinical or regulatory approval. The compound acts as an inhibitor of poly [ADP-ribose] polymerase 1 (PARP1), a key enzyme involved in DNA repair processes, and has demonstrated high binding affinity (Ki ~6 nM). While not approved for any medical indication, it serves as a valuable scaffold in medicinal chemistry research due to its potential anti-inflammatory, antimicrobial, antitumor, and antiviral activities. Its unique structure makes it useful for drug design and biological studies focused on PARP inhibition[1][2][4].

Other names
2-(3-methoxyphenyl)-1H-benzimidazole-4-carboxamide2-(3'-methoxyphenyl)-1-H-benzimidazole-4-carboxamideQ27094866Q-27094866Q 270948662-(3''-methoxyphenyl) benzimidazole-4-carboxamide2-(3-methoxyphenyl)-1H-benzoimidazole-4-carboxylic acid amide
02

Targets

PARP2 (Poly (adp-ribose) polymerase 2)

Beyond the preview

Go deeper on 2-(3'-methoxyphenyl) benzimidazole-4-carboxamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2-(3'-methoxyphenyl) benzimidazole-4-carboxamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call